All

All
Insight
Research Services
Preclinical CRO
Animal Resource Bank

About Us

Aniphe BioLab Inc.is committed to providing high‑quality research services and laboratory animal resources for pharmaceutical R&D worldwide, driving life sciences through technological innovation, supporting new drug development with professionalism and integrity, elucidating biological phenotypes, and uncovering the root causes of disease.

Explore more

Company Profile

Beyond creating animal models, we are building the puzzle of health in the era of genome editing.

Disease animal model

Pharmacological and Toxicological Evaluation

Gene Editing and Breeding

Aniphe Biolaboratory Inc., established in 2018, is a biotechnology company specializing in model animals and preclinical efficacy evaluation.

Leveraging its comprehensive SPF‑grade laboratory animal center, Aniphe BioLab has established an integrated service platform encompassing gene editing, model animal breeding, the generation of human disease models, and pharmacological and efficacy evaluations. The company focuses on supporting research in oncology, neuroscience, metabolism, and other key areas, providing research institutions and innovative pharmaceutical companies with reliable models, robust data, and expert technical support.

We harness gene editing to unravel the mechanisms of life and leverage animal models to bridge disease research with drug innovation, bringing each experiment closer to the truth about disease.

1400 M²

Company area

5000 +cage

Number of squirrel cages

10000 +

Service Cases

36 +

Business Coverage Area

Development History

Looking ahead, the company will remain steadfastly focused on the life sciences research sector and new‑drug development, with a global outlook, striving to become an enterprise that contributes meaningfully to societal progress.

2018

Focusing on the fields of laboratory animals and gene editing, we are deeply committed to developing high-quality animal resources, optimizing genetic stock, and providing related model‑building services.

2019-2020

Strategic Focus & Market Expansion
Our business spans China’s key biopharmaceutical clusters, and we have established a dual‑engine strategy of “gene‑editing models + disease‑model–driven precision research,” thereby building distinctive competitive advantages.

2021-2022

Industry–University–Research Collaboration & Ecosystem Co‑construction
Established a joint laboratory with Zhengzhou University, built a collaborative platform for industry–university–research cooperation, and focused on the development of customized models in areas such as neuroscience and oncology.

2023-2024

Enhancing Indigenous Industrial Capabilities & Standardization Development
We have pioneered an innovative CRISPR in vivo library‑screening technology to accelerate the translation of research findings into practical applications. We have obtained both the “License for the Production of Laboratory Animals” and the “License for the Use of Laboratory Animals,” been recognized as a national high‑tech enterprise, and undertaken a comprehensive upgrade of our compliance‑driven operational framework.

2025

System Upgrade & Forward-Looking Planning
We are upgrading our end-to-end service matrix for disease‑model customization and pharmacological efficacy evaluation, proactively positioning ourselves in the preclinical innovation space, and developing an integrated solution that combines “technology empowerment, service efficiency enhancement, and ecosystem integration,” thereby laying a robust foundation for the high‑quality development of the biopharmaceutical industry.

2026

Core Drive & Revolutionary Breakthroughs
Driven by gene-editing technologies and leveraging precision animal models, we are deeply engaged in the disease‑modeling space, continuously advancing innovation and breakthroughs in basic biomedical research and preclinical efficacy studies.

2018

2019-2020

2021-2022

2023-2024

2025

2026

Company platform

Animal facility environment Rodent cage display Cellular and Molecular Biology Experimental Platform Phenotype Detection Platform Image Sharing Platform

Animal facility environment

Rodent cage display

Cellular and Molecular Biology Experimental Platform

Small Animal Ultrasound Imaging System

Water Maze

Fully automatic biochemical analyzer

Small-animal MRI scanner

Two-photon laser scanning microscope

High-Resolution Micro-CT for Small Animals

Customer Feedback

During preclinical evaluation, data integrity and traceability are of paramount importance. Ailinfei’s robust experimental record‑keeping system and quality‑management processes enable us to confidently advance subsequent efficacy validation and translational research.

Dr. Liu, Principal Investigator of the Research Project

Henan University of Traditional Chinese Medicine

The most profound impression from this collaboration is its professionalism and adherence to rigorous standards. Aniphe BioLab not only successfully completed the experimental tasks but also proactively offered optimization recommendations from a research‑design perspective, helping us mitigate experimental risks and enhance research efficiency.

Teacher Zhao · Principal Investigator of the Research Project

Zhengzhou University

During project execution, the technical team responded promptly and swiftly adjusted the protocol to address issues arising in the experimental process. From model establishment and drug administration to biomarker analysis, the entire workflow was seamlessly integrated, enabling the research project to advance with greater efficiency.

Teacher Chen · Principal Investigator of the Research Project

China Pharmaceutical University

Local services

The tech expert is here! Let’s head over to Jiangsu Provincial Second Traditional Chinese Medicine Hospital to chat about all things research.

Your mouse has arrived! We deliver mice right to your door—just for you!

Your mice have arrived, and your research partner is in place!

Contact

If you need help, you can… Contact Us

If you are seeking a professional solution, please contact us.

Phone:

025-8520 8061

Order email: